Category: Chronic Pulmonary Disorders

Chronic Pulmonary Disorders

Experimental Therapy for Rare ALS Tested

Mayo Clinic researchers reported early findings from an experimental treatment designed for a single patient with a rare genetic form of amyotrophic lateral sclerosis (ALS).

Chronic Pulmonary Disorders

California Moves to Ban High-Silica Engineered Stone Countertops to Protect Workers

Cal/OSHA issued draft rules to prohibit the fabrication of artificial stone products containing more than 1% crystalline silica, citing lung risks to workers.

Chronic Pulmonary Disorders

COPD Origins Tied to Early Child Lung Development, Air Pollution

Children with an inherited risk for COPD show slower lung growth when exposed to higher levels of air pollution during early childhood.

Asthma

Asthma Antiviral Nasal Spray Secures Funding for Clinical Trial

A clinical trial will evaluate a weekly dry powder nasal spray's ability to boost natural defenses and prevent asthma infections.

COPD

Insurance Barriers Limit Pulmonary Rehab Access

Insurance coverage is a significant barrier to accessing virtual pulmonary rehabilitation programs for people with COPD.

Cystic fibrosis

Wearable Sweat Test Stickers for Cystic Fibrosis

Wearable stickers can accurately measure sweat chloride levels in cystic fibrosis patients in under an hour without specialized laboratory equipment.

Pulmonary Fibrosis

Lung Health Navigators for Pulmonary Fibrosis Patients

The American Lung Association provides personalized guidance from RTs and nurses to help pulmonary fibrosis patients manage lung disease.

Allergies

How Hurricane Flooding Affects Respiratory Symptoms

Researchers identified the factors that are most likely to create hazardous respiratory conditions inside homes after hurricane-related flooding.

Other Chronic Diseases

Brinsupri/Brensocatib Approved for Bronchiectasis in Japan

Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Brinsupri (brensocatib 25-mg tablet), an oral, once-daily treatment for non-cystic fibrosis bronchiectasis (NCFB) in adults and pediatric patients 12 years and older, according to Insmed Inc.